DENTSPLY SIRONA (NASDAQ:XRAY) Cut to “Hold” at StockNews.com

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Tuesday.

Other analysts have also recently issued research reports about the stock. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Needham & Company LLC dropped their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Leerink Partnrs lowered DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Evercore ISI cut their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY traded up $0.42 during mid-day trading on Tuesday, hitting $18.88. 3,937,339 shares of the stock were exchanged, compared to its average volume of 3,144,620. The firm’s 50-day simple moving average is $23.66 and its 200 day simple moving average is $25.25. The stock has a market capitalization of $3.75 billion, a price-to-earnings ratio of -9.12, a price-to-earnings-growth ratio of 1.80 and a beta of 1.02. DENTSPLY SIRONA has a fifty-two week low of $17.21 and a fifty-two week high of $37.60. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating the consensus estimate of $0.48 by $0.02. The business had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company’s revenue was up .4% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 earnings per share. As a group, equities analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Large investors have recently modified their holdings of the company. UMB Bank n.a. raised its position in DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in DENTSPLY SIRONA in the third quarter worth $27,000. LRI Investments LLC increased its stake in shares of DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 564 shares in the last quarter. Rothschild Investment LLC purchased a new position in shares of DENTSPLY SIRONA during the second quarter valued at approximately $32,000. Finally, Kennebec Savings Bank bought a new stake in DENTSPLY SIRONA in the third quarter worth $35,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.